FREYMAN THOMAS C 4
4 · AbbVie Inc. · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
AbbVie (ABBV) Director Thomas C. Freyman Receives 1,118 RSUs
What Happened
Thomas C. Freyman, a director of AbbVie Inc. (ABBV), was granted 1,118 restricted stock units (RSUs) on 2026-05-08. The award is reported at $0.00 per unit (transaction code A) because these are compensation awards rather than an open-market purchase or sale. RSUs will be settled one-for-one into AbbVie common stock upon the earlier of the director’s separation from service, death, or a change in control under the company’s 2013 Incentive Stock Program.
Key Details
- Transaction date: 2026-05-08; Form 4 filed: 2026-05-12 (filed within the standard two-business-day window).
- Security: Restricted stock units (RSUs); Amount: 1,118 units; Reported price: $0.00 (award).
- Shares owned after transaction: Not specified on this Form 4.
- Footnotes: F1 explains RSUs vest/settle 1:1 upon separation, death, or change in control. F2 and F3 note certain shares are held in trusts (spouse is trustee) and the reporting person disclaims beneficial ownership of those trust-held shares.
- Transaction code: A = Award/Grant.
Context
RSU awards to directors are routine compensation and do not represent an open-market purchase or sale that would signal immediate bullish or bearish insider sentiment. The award becomes actual AbbVie shares only upon the specified triggering events (separation, death, or change in control). Trust-related disclosures simply describe legal ownership arrangements and do not necessarily indicate trading intent.
Insider Transaction Report
- Award
Common Stock, $0.01 par value
[F1]2026-05-08+1,118→ 127,869 total
- 4,000(indirect: By Trust)
Common Stock, $0.01 par value
[F2] - 1,941(indirect: By Trust)
Common Stock, $0.01 par value
[F3] - 1,941(indirect: By Trust)
Common Stock, $0.01 par value
[F3]
Footnotes (3)
- [F1]These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
- [F2]The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
- [F3]Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.